Alterome Therapeutics IPO

Alterome Therapeutics is a biopharmaceutical company with a mission to develop targeted cancer therapies, focusing on hard-to-treat cancer targets. The company utilizes a combination of advanced scientific disciplines, including chemistry, biology, pharmacology, and genomics aiming to create selective, small-molecule therapies aimed at transforming the lives of its patients. Alterome Therapeutics was founded by Eric A Murphy in 2021 and is headquartered in San Diego, CA.

Register for Details

For more details on financing and valuation for Alterome Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Alterome Therapeutics

Forge green plus iconForge green minus icon

What is Alterome Therapeutics's IPO price?

The IPO price for Alterome Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Alterome Therapeutics?

Alterome Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Alterome Therapeutics shares pre-IPO?

If you own Alterome Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Alterome Therapeutics a publicly traded company?

Alterome Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Alterome Therapeutics's funding to date?

Alterome Therapeutics has raised $231.07MM to date.
Forge green plus iconForge green minus icon

When was Alterome Therapeutics founded?

Alterome Therapeutics was founded in 2021.

Who are Alterome Therapeutics's major investors?

Goldman Sachs Asset Management
Invus Opportunities
Canaan Partners
Blue Owl Capital
Boxer Capital
Nextech Invest
Vida Ventures (Boston)
Colt Ventures
Driehaus Capital Management

Alterome Therapeutics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
4/3/2024 Series B $132MM raised $XXX.XX $XXX.XX
11/2/2022 Series A-2 $35.27MM raised $XXX.XX $XXX.XX
1/19/2022 Series A $63.8MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.